Mair Therapeutics Announces Scientific Collaboration with Radboud University to Advance TMEM175 Agonists for Parkinson's Disease ...Middle East

NIJMEGEN, The Netherlands, Jan. 26, 2026 /PRNewswire/ -- Mair Therapeutics, a Dutch biotechnology company pioneering lysosomal-targeted therapies for neurodegenerative diseases, today announced a scientific collaboration with Radboud University to accelerate the discovery of...

Hence then, the article about mair therapeutics announces scientific collaboration with radboud university to advance tmem175 agonists for parkinson s disease was published today ( Monday 26/01/2026 - 03:05 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Mair Therapeutics Announces Scientific Collaboration with Radboud University to Advance TMEM175 Agonists for Parkinson's Disease )

Also on site :

• Tayvis Fans Are 'Sobbing' Over 'Precious' Photo of Donna Kelce and Andrea Swift: 'The In-Laws Are Hanging Out'
• ‘When Calls the Heart’ Season 13 Episode 4 Recap: Towns Turn on Each Other as the Wildfire Mystery Deepens
• China launches investigation into top general – MOD